Evidence map›Paper›PMID 26765939›Full record

ArticleAIDS (London, England)2016

Adult life expectancy trends in the era of antiretroviral treatment in rural Uganda (1991-2012).

Gershim Asiki, Georges Reniers, Robert Newton, Kathy Baisley, Jessica Nakiyingi-Miiro, Emma Slaymaker, Ivan Kasamba, Janet Seeley, Jim Todd, Pontiano Kaleebu and 1 more

2 registry-linked trialsAbstract read
In one paragraph

Article in AIDS (London, England), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04070248 unknown statusnot on this mapstarted 2019, after this paper: background citation

Investigating the Association Between Altered Lung MicroBiome and HIV-associated Chronic Obstructive Pulmonary Disease in a Ugandan Cohort

TypeobservationalSponsorMakerere UniversityRan2019 to 2021Enrolled200ConditionsCOPD, HIV/AIDSArmsNo intervention
NCT05223114 completednot on this mapstarted 2022, after this paper: background citation

Airway Microbiome and Th17-mediated Inflammation in COPD Among HIV-infected Individuals in a Rural Ugandan Cohort

TypeobservationalSponsorMakerere UniversityRan2022 to 2023Enrolled160ConditionsCOPD, HIV Infections, Respiratory DiseaseArmsNot applicable (N/A)
3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Observational
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Gershim AsikiaMedical Research Council/Uganda Virus Research Institute, Uganda Research Unit on AIDS, Entebbe, UgandabDepartment of Women's and Children's Health, Karolinska Institute, Stockholm, SwedencLondon School of Hygiene and Tropical Medicine, LondondDepartment of Health Sciences, University of York, YorkeTropical Epidemiology Group, London School of Hygiene and Tropical Medicine, London, UK.
Georges Reniers
Robert Newton
Kathy Baisley
Jessica Nakiyingi-Miiro
Emma Slaymaker
Ivan Kasamba
Janet Seeley
Jim Todd
Pontiano Kaleebu
Anatoli Kamali

Funding

Medical Research Council G0700837Wellcome Trust 075886Wellcome Trust 085477Wellcome Trust 085477/Z/08/Z
6 · The paper itself

Abstract

objectiveTo estimate the impact of antiretroviral therapy (ART) on population-wide adult life expectancy. STUDY

designA population-based open cohort study with repeated HIV status measurements and registration of vital events in Southwestern Uganda (1991-2012).

methodsNonparametric survival analysis techniques are used for estimating trends in the adult life expectancy of the general population (aged 15 and above), the adult life expectancy by HIV status, and the adult life expectancy deficit. The life expectancy deficit is estimated as the difference between overall life expectancy and life expectancy of the HIV-negative population. All estimates are disaggregated by sex.

resultsBetween 1991-1993 and 2009-2012, population-wide adult life expectancy increased from 39.3 [95% confidence interval (CI): 35.9-42.8] to 56.1 years (95% CI: 54.0-58.5) in women, and from 38.6 (95% CI: 35.4-42.1) to 51.4 years (95% CI: 49.2-53.7) in men. Most of the adult life expectancy gains coincide with the introduction of ART in 2004; as evidenced by an increase in the adult life expectancy of people living with HIV between 2000-2002 and 2009-2012 of 22.9 and 20.0 years for women and men, respectively. Over the whole period of observation, the adult life expectancy deficit associated with HIV decreased from 16.1 (95% CI: 12.7-19.8) to 6.0 years (95% CI: 4.1-7.8) among women, and from 16.0 (95% CI: 12.1-19.9) to 2.8 years (95% CI: 1.2-4.6) among men.

conclusionPopulation-wide life expectancy increased substantially, largely driven by reductions in HIV-related mortality. Women have gained more adult life years than men since the introduction of ART, but the burden of HIV in terms of the life years lost is still larger for women than it is for men.

Indexed as

AdolescentAdultAgedAged, 80 and overAnti-Retroviral AgentsCohort StudiesFemaleHIV InfectionsHumansLife ExpectancyMaleMiddle AgedRural PopulationSex FactorsUgandaYoung AdultAnti-Retroviral Agents

Identifiers

PMID26765939
PMCPMC7612613

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.